Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association

Stroke. 2023 Oct;54(10):e465-e479. doi: 10.1161/STR.0000000000000443. Epub 2023 Aug 23.

Abstract

Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. A writing group of experts was selected to conduct a literature search, summarize the current knowledge on the topic, and provide a road map for future investigation. The document presents an update in the definitions of moyamoya disease and syndrome, modern methods for diagnosis, and updated information on pathophysiology, epidemiology, and both medical and surgical treatment. Despite recent advancements, there are still many unresolved questions about moyamoya disease and syndrome, including lack of unified diagnostic criteria, reliable biomarkers, better understanding of the underlying pathophysiology, and stronger evidence for treatment guidelines. To advance progress in this area, it is crucial to acknowledge the limitations and weaknesses of current studies and explore new approaches, which are outlined in this scientific statement for future research strategies.

Keywords: AHA Scientific Statements; cerebral revascularization; diagnosis; guidelines as topic; hemorrhagic stroke; moyamoya disease.

Publication types

  • Review

MeSH terms

  • Adult
  • American Heart Association
  • Humans
  • Moyamoya Disease* / diagnosis
  • Moyamoya Disease* / epidemiology
  • Moyamoya Disease* / therapy
  • Stroke* / diagnosis
  • Stroke* / epidemiology
  • Stroke* / therapy
  • United States / epidemiology

Supplementary concepts

  • Moyamoya disease 1